Proteomics

Dataset Information

0

Inhibition of mPGES-1 or COX-2 Results in Different Proteomic and Lipidomic Profiles in A549 Lung Cancer Cells


ABSTRACT: We compared the effects of mPGES-1 inhibitor Compound III (CIII) with the cyclooxygenase (COX)-2 inhibitor NS-398 on protein and lipid profiles in interleukin (IL)-1β induced A549 lung cancer cells using mass spectrometry. Inhibition of mPGES-1 decreased PGE2 production and increased PGF2α and thromboxane B2 (TXB2) formation, while inhibition of COX-2 decreased the production of all three prostanoids. Our proteomics results revealed that CIII downregulated multiple canonical pathways including eIF2, eIF4/P70S6K, and mTOR signaling, compared to NS-398 that activated these pathways.

INSTRUMENT(S): Q Exactive

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Epithelial Cell Of Lung, Cell Culture

DISEASE(S): Lung Cancer

SUBMITTER: Elena Ossipova  

LAB HEAD: Per-Johan Jakobsson

PROVIDER: PXD013490 | Pride | 2019-05-20

REPOSITORIES: Pride

altmetric image

Publications

Inhibition of mPGES-1 or COX-2 Results in Different Proteomic and Lipidomic Profiles in A549 Lung Cancer Cells.

Bergqvist Filip F   Ossipova Elena E   Idborg Helena H   Raouf Joan J   Checa Antonio A   Englund Karin K   Englund Petter P   Khoonsari Payam Emami PE   Kultima Kim K   Wheelock Craig E CE   Larsson Karin K   Korotkova Marina M   Jakobsson Per-Johan PJ  

Frontiers in pharmacology 20190607


Pharmacological inhibition of microsomal prostaglandin E synthase (mPGES)-1 for selective reduction in prostaglandin E<sub>2</sub> (PGE<sub>2</sub>) biosynthesis is protective in experimental models of cancer and inflammation. Targeting mPGES-1 is envisioned as a safer alternative to traditional non-steroidal anti-inflammatory drugs (NSAIDs). Herein, we compared the effects of mPGES-1 inhibitor Compound III (CIII) with the cyclooxygenase (COX)-2 inhibitor NS-398 on protein and lipid profiles in  ...[more]

Similar Datasets

2011-06-01 | GSE26322 | GEO
2011-06-01 | E-GEOD-26322 | biostudies-arrayexpress
2020-03-02 | PXD016803 | Pride
2023-03-11 | PXD031345 | Pride
2009-03-27 | E-GEOD-7584 | biostudies-arrayexpress
2020-01-23 | E-MTAB-8673 | biostudies-arrayexpress
2019-11-11 | PXD015475 | Pride
| PRJEA65019 | ENA
2021-09-09 | PXD025102 | Pride
2022-09-25 | PXD030258 | Pride